BNP Paribas Financial Markets
CVS icon

BNP Paribas Financial Markets’s CVS Health CVS Stock Holding History

BNP Paribas Financial Markets’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$262M Sell
2,530,197
-70,491
-3% -$6.29M 0.09% 182
2026
Q1 		$187M Sell
2,600,688
-658,988
-20% -$50.8M 0.09% 225
2025
Q4 		$259M Buy
3,259,676
+2,160,576
+197% +$170M 0.12% 156
2025
Q3 		$82.9M Sell
1,099,100
-870,321
-44% -$59.6M 0.04% 426
2025
Q2 		$136M Sell
1,969,421
-1,837,295
-48% -$120M 0.08% 230
2025
Q1 		$258M Buy
3,806,716
+1,112,424
+41% +$66.6M 0.15% 137
2024
Q4 		$121M Buy
2,694,292
+426,264
+19% +$23.9M 0.07% 289
2024
Q3 		$143M Buy
2,268,028
+460,660
+25% +$26.9M 0.1% 207
2024
Q2 		$107M Buy
1,807,368
+247,571
+16% +$15.5M 0.09% 227
2024
Q1 		$124M Buy
1,559,797
+844,975
+118% +$64.5M 0.11% 193
2023
Q4 		$56.4M Buy
714,822
+108,155
+18% +$7.7M 0.06% 324
2023
Q3 		$42.4M Sell
606,667
-1,596,568
-72% -$113M 0.05% 343
2023
Q2 		$152M Sell
2,203,235
-350,361
-14% -$24.9M 0.19% 101
2023
Q1 		$190M Buy
2,553,596
+1,035,923
+68% +$86.9M 0.27% 80
2022
Q4 		$141M Buy
1,517,673
+1,146,573
+309% +$111M 0.22% 100
2022
Q3 		$35.4M Sell
371,100
-439,259
-54% -$43.5M 0.06% 394
2022
Q2 		$75.1M Buy
810,359
+323,849
+67% +$31.6M 0.12% 182
2022
Q1 		$49.2M Buy
486,510
+16,549
+4% +$1.74M 0.07% 286
2021
Q4 		$48.5M Sell
469,961
-365,586
-44% -$33.8M 0.07% 298
2021
Q3 		$70.9M Sell
835,547
-272,513
-25% -$22.8M 0.1% 224
2021
Q2 		$92.5M Buy
1,108,060
+124,509
+13% +$10.2M 0.12% 189
2021
Q1 		$74M Buy
983,551
+617,109
+168% +$45M 0.11% 203
2020
Q4 		$25M Sell
366,442
-679,269
-65% -$44.2M 0.05% 405
2020
Q3 		$61.1M Buy
1,045,711
+88,641
+9% +$5.52M 0.09% 226
2020
Q2 		$62.2M Sell
957,070
-590,591
-38% -$37.2M 0.11% 167
2020
Q1 		$91.8M Buy
1,547,661
+845,632
+120% +$56.5M 0.19% 111
2019
Q4 		$52.2M Buy
702,029
+350,929
+100% +$24.6M 0.1% 218
2019
Q3 		$22.1M Sell
351,100
-856,279
-71% -$50.7M 0.04% 458
2019
Q2 		$65.8M Buy
1,207,379
+647,715
+116% +$34.9M 0.13% 170
2019
Q1 		$30.2M Sell
559,664
-386,356
-41% -$23.8M 0.07% 325
2018
Q4 		$62M Buy
946,020
+12,762
+1% +$953K 0.15% 157
2018
Q3 		$73.5M Sell
933,258
-7,796
-0.8% -$557K 0.11% 190
2018
Q2 		$60.6M Sell
941,054
-305,131
-24% -$20.1M 0.1% 191
2018
Q1 		$77.5M Buy
1,246,185
+17,802
+1% +$1.28M 0.15% 130
2017
Q4 		$89.1M Buy
1,228,383
+332,032
+37% +$24.1M 0.16% 135
2017
Q3 		$72.9M Buy
896,351
+176,025
+24% +$13.9M 0.18% 106
2017
Q2 		$58M Sell
720,326
-323,079
-31% -$25.5M 0.17% 112
2017
Q1 		$81.9M Buy
1,043,405
+243,465
+30% +$19.4M 0.22% 98
2016
Q4 		$63.1M Buy
799,940
+503,788
+170% +$40.8M 0.3% 63
2016
Q3 		$26.4M Sell
296,152
-56,719
-16% -$5.35M 0.11% 139
2016
Q2 		$33.8M Buy
352,871
+55,145
+19% +$5.5M 0.15% 96
2016
Q1 		$30.9M Sell
297,726
-409,909
-58% -$39.9M 0.13% 126
2015
Q4 		$69.2M Buy
707,635
+7,878
+1% +$772K 0.17% 104
2015
Q3 		$67.5M Buy
699,757
+481,936
+221% +$50.7M 0.17% 79
2015
Q2 		$22.8M Sell
217,821
-7,784
-3% -$795K 0.06% 180
2015
Q1 		$23.3M Sell
225,605
-335,563
-60% -$34M 0.06% 190
2014
Q4 		$54M Sell
561,168
-109,420
-16% -$9.64M 0.19% 91
2014
Q3 		$53.4M Sell
670,588
-209,843
-24% -$16.5M 0.05% 178
2014
Q2 		$66.4M Sell
880,431
-588,429
-40% -$44.5M 0.06% 136
2014
Q1 		$107M Buy
1,468,860
+885,370
+152% +$62.5M 0.08% 116
2013
Q4 		$41.8M Sell
583,490
-230,306
-28% -$14.8M 0.03% 186
2013
Q3 		$46.2M Buy
813,796
+720,559
+773% +$42.9M 0.03% 193
2013
Q2 		$5.33M Buy
+93,237
New +$5.4M ﹤0.01% 490

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

BNP Paribas Financial Markets's CVS Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its CVS Health (CVS) stake by 2.7% in Q2 2026, selling an estimated $6.29M and leaving 2,530,197 shares worth $262M. The position accounts for 0.09% of the portfolio, ranked #182.

BNP Paribas Financial Markets first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. 1,716 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • BNP Paribas Financial Markets held 2,530,197 shares of CVS Health worth $262M as of Q2 2026.
  • BNP Paribas Financial Markets sold 70,491 CVS Health shares in Q2 2026, an estimated $6.29M.
  • CVS Health made up 0.09% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #182 holding.
  • BNP Paribas Financial Markets first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • 1,716 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.